1. Home
  2. QRHC vs ALGS Comparison

QRHC vs ALGS Comparison

Compare QRHC & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quest Resource Holding Corporation

QRHC

Quest Resource Holding Corporation

HOLD

Current Price

$1.28

Market Cap

29.3M

Sector

Utilities

ML Signal

HOLD

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

HOLD

Current Price

$5.53

Market Cap

33.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QRHC
ALGS
Founded
N/A
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.3M
33.0M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
QRHC
ALGS
Price
$1.28
$5.53
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$39.33
AVG Volume (30 Days)
33.8K
68.5K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.30
EPS
N/A
N/A
Revenue
$138,346,327.00
$2,186,000.00
Revenue This Year
$3.67
$32.20
Revenue Next Year
N/A
$4.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$4.80
52 Week High
$2.41
$13.69

Technical Indicators

Market Signals
Indicator
QRHC
ALGS
Relative Strength Index (RSI) 48.85 49.74
Support Level $1.09 $4.80
Resistance Level $1.39 $5.94
Average True Range (ATR) 0.14 0.38
MACD -0.02 0.06
Stochastic Oscillator 28.89 57.29

Price Performance

Historical Comparison
QRHC
ALGS

About QRHC Quest Resource Holding Corporation

Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations, etc.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: